津普森 |
B600092-100mg |
100mg |
现货 |
601514-19-6 |
3-((6-(3-氨基苯基)-7H-吡咯并[2,3-d]... |
98%,B |
1,465.60
1,465.60
|
|
津普森 |
B600092-25mg |
25mg |
现货 |
601514-19-6 |
3-((6-(3-氨基苯基)-7H-吡咯并[2,3-d]... |
98%,B |
507.80
507.80
|
|
津普森 |
B600092-50mg |
50mg |
现货 |
601514-19-6 |
3-((6-(3-氨基苯基)-7H-吡咯并[2,3-d]... |
98%,B |
862.50
862.50
|
|
罗恩 |
R023267-10mg |
10mg |
5~7个工作日 |
601514-19-6 |
TWS119 TWS119 |
95% |
865.00
865.00
|
|
罗恩 |
R023267-25mg |
25mg |
5~7个工作日 |
601514-19-6 |
TWS119 TWS119 |
95% |
1,555.00
1,555.00
|
|
罗恩 |
R023267-50mg |
50mg |
5~7个工作日 |
601514-19-6 |
TWS119 TWS119 |
95% |
2,450.00
2,450.00
|
|
Selleck |
S159010mg |
10mg |
现货 |
601514-19-6 |
TWS119 |
|
982.76
982.76
|
|
Selleck |
S159025mg |
25mg |
现货 |
601514-19-6 |
TWS119 |
|
2,191.51
2,191.51
|
|
Selleck |
S159050mg |
50mg |
现货 |
601514-19-6 |
TWS119 |
|
3,853.85
3,853.85
|
|
毕得 |
BD301674-50mg |
50mg |
现货 |
601514-19-6 |
3-((6-(3-氨基苯基)-7H-吡咯并[2,3-d]... 3-((6-(3-Aminophenyl)-7H-pyr... |
99% |
1,250.00
1,250.00
|
|
毕得 |
BD301674-25mg |
25mg |
现货 |
601514-19-6 |
3-((6-(3-氨基苯基)-7H-吡咯并[2,3-d]... 3-((6-(3-Aminophenyl)-7H-pyr... |
99% |
736.00
736.00
|
|
阿拉丁 |
T126075-10mg |
10mg |
现货 |
601514-19-6 |
TWS119,细胞渗透性GSK-3β抑制剂 TWS119 |
Moligand™, ≥95% |
720.90
720.90
|
|
阿拉丁 |
T126075-25mg |
25mg |
现货 |
601514-19-6 |
TWS119,细胞渗透性GSK-3β抑制剂 TWS119 |
Moligand™, ≥95% |
1,295.90
1,295.90
|
|
阿拉丁 |
T126075-50mg |
50mg |
现货 |
601514-19-6 |
TWS119,细胞渗透性GSK-3β抑制剂 TWS119 |
Moligand™, ≥95% |
2,041.90
2,041.90
|
|
阿拉丁 |
T408372-1ml |
1ml |
期货,请咨询 |
601514-19-6 |
TWS119 TWS119 |
Moligand™, 10mM in DMSO |
456.90
456.90
|
|
阿拉丁 |
T126075-5mg |
5mg |
现货 |
601514-19-6 |
TWS119,细胞渗透性GSK-3β抑制剂 TWS119 |
Moligand™, ≥95% |
399.90
399.90
|
|
麦克林 |
T861007-10mg |
10mg |
现货 |
601514-19-6 |
TWS119 TWS119 |
>98% |
520.00
520.00
|
|
梯希爱 |
T3605-5MG |
5MG |
现货 |
601514-19-6 |
TWS 119 TWS 119 |
95.0% |
390.00
390.00
|
|
梯希爱 |
T3605-25MG |
25MG |
现货 |
601514-19-6 |
TWS 119 TWS 119 |
95.0% |
1,350.00
1,350.00
|
|